Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

Fig. 3

Changes of chemokines in patients with irAEs. Measurement of chemokines after vaccination in patients under PD-1 blockade. A comparison was made between patients that developed sever grade 3/4 irAEs and patients with no side effects of PD-1 blockade. While CXCL9 (a), CXCL10 (b) and CCL17 (c) showed a non-significant trend towards an increased level in patients with irAEs, CCL2 (d) was lower in patients who experienced irAEs. *p < 0.05 by Student’s t test

Back to article page